Human medicines European public assessment report (EPAR): Cervarix, human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Immunization, Date of authorisation: 20/09/2007, Revision: 32, Status: Authorised

2019 ◽  
Author(s):  
Keyword(s):  
Human Papillomavirus ◽  
Cervical Dysplasia ◽  
Human Papillomavirus Vaccine ◽  
Papillomavirus Infections ◽  
Assessment Report ◽  
European Public ◽  
European Public Assessment Report ◽  
Papillomavirus Vaccine ◽  
Uterine Cervical Dysplasia

Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women: A Systematic Review and Meta-analysis

2020 ◽  
Vol 75 (8) ◽  
pp. 475-476
Author(s):  
Katie Lichter ◽  
Danielle Krause ◽  
Jingwen Xu ◽  
Sung Huang Laurent Tsai ◽  
Camille Hage ◽  
...  
Keyword(s):  
Systematic Review ◽  
Human Papillomavirus ◽  
Meta Analysis ◽  
Cervical Dysplasia ◽  
Human Papillomavirus Vaccine ◽  
Papillomavirus Vaccine

scholarly journals Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women

2020 ◽  
Vol 135 (5) ◽  
pp. 1070-1083 ◽  
Author(s):  
Katie Lichter ◽  
Danielle Krause ◽  
Jingwen Xu ◽  
Sung Huang Laurent Tsai ◽  
Camille Hage ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Cervical Dysplasia ◽  
Human Papillomavirus Vaccine ◽  
Papillomavirus Vaccine
Sign in / Sign up

Export Citation Format

Share Document